Fumagalli F - Search Results

1

Targeted therapy for allergic asthma: predicting and evaluating response to omalizumab.

Tarantini F, Braido F, Baiardini I, Fumagalli F, Passalacqua G, Canonica GW. Tarantini F, et al. Among authors: fumagalli f. Expert Rev Clin Immunol. 2007 Jul;3(4):463-7. doi: 10.1586/1744666X.3.4.463. Expert Rev Clin Immunol. 2007. PMID: 20477152

2

Antihistamines in the treatment of bronchial asthma. Present knowledge and future perspectives.

Mincarini M, Pasquali M, Cosentino C, Fumagalli F, Scordamaglia A, Quaglia R, Canonica GW, Passalacqua G. Mincarini M, et al. Among authors: fumagalli f. Pulm Pharmacol Ther. 2001;14(4):267-76. doi: 10.1006/pupt.2001.0292. Pulm Pharmacol Ther. 2001. PMID: 11440555 Review. No abstract available.

3

Safety of allergen-specific sublingual immunotherapy and nasal immunotherapy.

Passalacqua G, Fumagalli F, Guerra L, Canonica GW. Passalacqua G, et al. Among authors: fumagalli f. Chem Immunol Allergy. 2003;82:109-18. doi: 10.1159/000071545. Chem Immunol Allergy. 2003. PMID: 12947997 Review.

4

Sublingual immunotherapy.

Passalacqua G, Guerra Enrico Compalati L, Pasquali M, Fumagalli F, Canonica GW. Passalacqua G, et al. Among authors: fumagalli f. Rev Alerg Mex. 2003 Nov-Dec;50(6):220-5. Rev Alerg Mex. 2003. PMID: 14968986 Review.

5

Aerobiological diagnosis of respiratory allergy by a personal sampler: two case reports.

Fiorina A, Scordamaglia A, Fumagalli F, Canonica GW, Passalacqua G. Fiorina A, et al. Among authors: fumagalli f. J Investig Allergol Clin Immunol. 2003;13(4):284-5. J Investig Allergol Clin Immunol. 2003. PMID: 14989120

6

Antihistamines: do they work? Further well-controlled trials involving larger samples are needed.

Fumagalli F, Baiardini I, Pasquali M, Compalati E, Guerra L, Massacane P, Canonica GW. Fumagalli F, et al. Allergy. 2004 Aug;59 Suppl 78:74-7. doi: 10.1111/j.1398-9995.2004.00573.x. Allergy. 2004. PMID: 15245363 Review.

7

Sublingual and oral immunotherapy.

Canonica GW, Compalati E, Fumagalli F, Passalacqua G. Canonica GW, et al. Among authors: fumagalli f. Immunol Allergy Clin North Am. 2004 Nov;24(4):685-704, vii. doi: 10.1016/j.iac.2004.07.001. Immunol Allergy Clin North Am. 2004. PMID: 15474866 Review.

8

A new tool to evaluate the impact of chronic urticaria on quality of life: chronic urticaria quality of life questionnaire (CU-QoL).

Baiardini I, Pasquali M, Braido F, Fumagalli F, Guerra L, Compalati E, Braga M, Lombardi C, Fassio O, Canonica GW. Baiardini I, et al. Among authors: fumagalli f. Allergy. 2005 Aug;60(8):1073-8. doi: 10.1111/j.1398-9995.2005.00833.x. Allergy. 2005. PMID: 15969690

9

Safety profile of sublingual immunotherapy.

Passalacqua G, Guerra L, Fumagalli F, Canonica GW. Passalacqua G, et al. Among authors: fumagalli f. Treat Respir Med. 2006;5(4):225-34. doi: 10.2165/00151829-200605040-00001. Treat Respir Med. 2006. PMID: 16808542

10

New insights in sublingual immunotherapy.

Passalacqua G, Guerra L, Compalati E, Fumagalli F, Cirillo A, Canonica GW. Passalacqua G, et al. Among authors: fumagalli f. Curr Allergy Asthma Rep. 2006 Sep;6(5):407-12. doi: 10.1007/s11882-996-0014-7. Curr Allergy Asthma Rep. 2006. PMID: 16899203 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

352 results

Search Page

Filters